Paying users zone. Data is covered by .

  • Get to Allergan PLC for $13.99, or

  • get to whole website for at least 3 months from $49.99.

 

$13.99

Income Statement Quarterly Data

Difficulty: Beginner

Allergan PLC, Consolidated Income Statement (quarterly data)

USD $ in thousands

 
3 months ended Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013 Sep 30, 2013 Jun 30, 2013 Mar 31, 2013
Net revenues
Cost of sales, excludes amortization and impairment of acquired intangibles including product rights
Gross profit
Research and development
Selling and marketing
General and administrative
Amortization
Goodwill impairments
In-process research and development impairments
Loss on assets held for sale
Asset sales and impairments, net
Operating income (loss)
Interest income
Interest expense
Other income (expense), net
Other income (expense), net
Income (loss) before income taxes and noncontrolling interest
(Provision) benefit for income taxes
Net income (loss) from continuing operations, net of tax
Income (loss) from discontinued operations, net of tax
Net income (loss)
(Income) loss attributable to noncontrolling interest
Net income (loss) attributable to shareholders
Dividends on preferred shares
Net income (loss) attributable to ordinary shareholders
Source: Allergan PLC, Quarterly and Annual Reports
Item Description The company
Net revenues Aggregate revenue recognized during the period (derived from goods sold, services rendered, insurance premiums, or other activities that constitute an entity's earning process). For financial services companies, also includes investment and interest income, and sales and trading gains. Allergan PLC's net revenues increased from Q3 2017 to Q4 2017 but then declined significantly from Q4 2017 to Q1 2018.
Operating income (loss) The net result for the period of deducting operating expenses from operating revenues. Allergan PLC's operating income (loss) increased from Q3 2017 to Q4 2017 but then slightly declined from Q4 2017 to Q1 2018.
Income (loss) before income taxes and noncontrolling interest Sum of operating profit and nonoperating income (expense) before income (loss) from equity method investments, income taxes, extraordinary items, cumulative effects of changes in accounting principles, and noncontrolling interest. Allergan PLC's income (loss) before income taxes and noncontrolling interest increased from Q3 2017 to Q4 2017 but then slightly declined from Q4 2017 to Q1 2018.
Net income (loss) from continuing operations, net of tax This represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses and taxes from ongoing operations before extraordinary items, cumulative effects of changes in accounting principles, and noncontrolling interest. Allergan PLC's net income (loss) from continuing operations, net of tax increased from Q3 2017 to Q4 2017 but then slightly declined from Q4 2017 to Q1 2018 not reaching Q3 2017 level.
Net income (loss) The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Allergan PLC's net income (loss) increased from Q3 2017 to Q4 2017 but then slightly declined from Q4 2017 to Q1 2018.
Net income (loss) attributable to shareholders The portion of consolidated profit or loss for the period, net of income taxes, which is attributable to the parent. If the entity does not present consolidated financial statements, the amount of profit or loss for the period, net of income taxes. Allergan PLC's net income (loss) attributable to shareholders increased from Q3 2017 to Q4 2017 but then slightly declined from Q4 2017 to Q1 2018.

Top